MX341622B - Una composicion acuosa que comprende un antigeno biologico y un polimero de acido acrilico. - Google Patents
Una composicion acuosa que comprende un antigeno biologico y un polimero de acido acrilico.Info
- Publication number
- MX341622B MX341622B MX2013015330A MX2013015330A MX341622B MX 341622 B MX341622 B MX 341622B MX 2013015330 A MX2013015330 A MX 2013015330A MX 2013015330 A MX2013015330 A MX 2013015330A MX 341622 B MX341622 B MX 341622B
- Authority
- MX
- Mexico
- Prior art keywords
- aqueous composition
- acrylic acid
- acid polymer
- biological
- composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Inorganic Chemistry (AREA)
- Organic Chemistry (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Virology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
Abstract
La presente invención se refiere a una composición acuosa que contiene un antígeno biológico y un polímero de ácido acrílico, caracterizada porque la composición comprende un electrolito para proveer una osmolaridad mayor que la osmolaridad de una solución de cloruro de sodio al 0.9%(p/v) en agua; y en donde la osmolaridad de dicha composición por lo menos 30% más alta que la osmolaridad de una solución de cloruro de sodio al 0.9% (p/v).
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP11171448 | 2011-06-27 | ||
US201161501866P | 2011-06-28 | 2011-06-28 | |
PCT/EP2012/062279 WO2013000876A1 (en) | 2011-06-27 | 2012-06-26 | An aqueous composition comprising a biological antigen and an acrylic acid polymer |
Publications (2)
Publication Number | Publication Date |
---|---|
MX2013015330A MX2013015330A (es) | 2014-02-17 |
MX341622B true MX341622B (es) | 2016-08-25 |
Family
ID=47423442
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2013015330A MX341622B (es) | 2011-06-27 | 2012-06-26 | Una composicion acuosa que comprende un antigeno biologico y un polimero de acido acrilico. |
Country Status (10)
Country | Link |
---|---|
US (1) | US8968744B2 (es) |
EP (1) | EP2723386A1 (es) |
JP (1) | JP6120836B2 (es) |
KR (1) | KR101877096B1 (es) |
CN (1) | CN103608041A (es) |
BR (1) | BR112013033522A8 (es) |
CA (1) | CA2839387C (es) |
MX (1) | MX341622B (es) |
RU (1) | RU2565443C2 (es) |
WO (1) | WO2013000876A1 (es) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB201315321D0 (en) * | 2013-08-28 | 2013-10-09 | Koninklijke Nederlandse Akademie Van Wetenschappen | Transduction Buffer |
JP2018020962A (ja) * | 2014-12-08 | 2018-02-08 | エヌエーアイ株式会社 | 新規アジュバント |
US10279031B2 (en) | 2016-05-11 | 2019-05-07 | Phibro Animal Health Corporation | Composition comprising antigens and a mucosal adjuvant and a method for using |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3178350A (en) | 1961-05-15 | 1965-04-13 | Cutler Lab Inc | Biologic antigens adjuvanted with a colloidally water-soluble polymer of acrylic acidcrosslinked with polyallyl sucrose or polyallyl pentaerythritol |
US3920811A (en) * | 1972-12-22 | 1975-11-18 | Cutter Lab | Adjuvant compositions |
JPH0678245B2 (ja) * | 1989-07-04 | 1994-10-05 | 東興薬品工業株式会社 | 鼻腔内噴霧投与用インフルエンザワクチンゲル製剤 |
TWI449533B (zh) | 2008-04-18 | 2014-08-21 | Intervet Int Bv | 防備胞內勞森菌(Lawsonia intracellularis)、豬肺炎黴漿菌(Mycoplasma hyopneumoniae)及豬環狀病毒(Porcine circo virus)用疫苗 |
WO2010025469A1 (en) * | 2008-08-29 | 2010-03-04 | Boehringer Ingelheim Vetmedica, Inc. | West nile virus vaccine |
-
2012
- 2012-06-26 CN CN201280031540.5A patent/CN103608041A/zh active Pending
- 2012-06-26 KR KR1020147001736A patent/KR101877096B1/ko active IP Right Grant
- 2012-06-26 JP JP2014517639A patent/JP6120836B2/ja not_active Expired - Fee Related
- 2012-06-26 CA CA2839387A patent/CA2839387C/en not_active Expired - Fee Related
- 2012-06-26 US US14/126,951 patent/US8968744B2/en not_active Expired - Fee Related
- 2012-06-26 RU RU2014102209/15A patent/RU2565443C2/ru active
- 2012-06-26 BR BR112013033522A patent/BR112013033522A8/pt not_active IP Right Cessation
- 2012-06-26 EP EP12732610.6A patent/EP2723386A1/en not_active Withdrawn
- 2012-06-26 WO PCT/EP2012/062279 patent/WO2013000876A1/en active Application Filing
- 2012-06-26 MX MX2013015330A patent/MX341622B/es active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
KR101877096B1 (ko) | 2018-07-10 |
US8968744B2 (en) | 2015-03-03 |
BR112013033522A2 (pt) | 2017-02-07 |
JP6120836B2 (ja) | 2017-04-26 |
MX2013015330A (es) | 2014-02-17 |
CA2839387A1 (en) | 2013-01-03 |
CA2839387C (en) | 2016-03-22 |
RU2014102209A (ru) | 2015-08-10 |
WO2013000876A1 (en) | 2013-01-03 |
US20140120135A1 (en) | 2014-05-01 |
RU2565443C2 (ru) | 2015-10-20 |
EP2723386A1 (en) | 2014-04-30 |
KR20140047670A (ko) | 2014-04-22 |
CN103608041A (zh) | 2014-02-26 |
JP2014518231A (ja) | 2014-07-28 |
BR112013033522A8 (pt) | 2018-03-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR113034A2 (es) | Formulación líquida de un conjugado de la hormona del crecimiento humano de efecto prolongado | |
EA201390631A1 (ru) | Композиция микобактериальных антигенов | |
PE20150223A1 (es) | Anticuerpos antagonistas mejorados contra factor-8 de crecimiento y diferenciacion y usos de los mismos | |
EA201600305A1 (ru) | Вариант белка opc2 pcv2 и содержащие его вирусоподобные частицы | |
CY1119269T1 (el) | Θεραπεια βλαβων που προκαλουνται απο ιους | |
BR112015014477A2 (pt) | composições para limpeza pessoal contendo aminoácido de zinco/haleto de trimetilglicina | |
BR112015008186A2 (pt) | formulação de um anticorpo estável e de baixa viscosidade | |
BR112014004637A2 (pt) | lente de menisco líquido com formulação de solução salina aprimorada | |
AR067087A1 (es) | Composicion de vacuna y metodo para elaborarla | |
EA201500701A1 (ru) | Способ создания вакцины против микоплазм | |
BR112013020586A2 (pt) | Uso de células derivadas de tecido do cordão umbilical | |
BR112014015342A8 (pt) | células-tronco pluripotentes induzidas de células derivadas do tecido do cordão umbilical humano | |
UA114719C2 (uk) | Рекомбінантний герпесвірус кої (khv) і вакцина для профілактики захворювання, що викликається khv | |
BR112014001409A2 (pt) | métodos e composições para vacinação contra staphylococcus aureus | |
BR112012017994B8 (pt) | composição líquida, uso de uma composição líquida, e, métodos para preparar uma composição líquida e para tratamento de um distúrbio | |
EA201190285A1 (ru) | Иммуногенные композиции, имеющие низкую концентрацию хлорида натрия | |
BR112014030509A2 (pt) | métodos para aumentar o progresso genético em uma linhagem ou raça de suíno usando células de esperma de sexo selecionado | |
MX341622B (es) | Una composicion acuosa que comprende un antigeno biologico y un polimero de acido acrilico. | |
BR112016007390A2 (pt) | vacina de haemophilus parasuis sorotipo tipo quatro | |
EA201391144A1 (ru) | Композиции для обработки волос | |
MX2016007224A (es) | Vacuna contra el circovirus porcino tipo 2. | |
BR112013023354A2 (pt) | vacina para rinite equina | |
TR201910409T4 (tr) | Sitrülin barındıran adjuvan bileşimi. | |
BR112014019486A8 (pt) | Uso de um oligossacarídeo não digerível como um suplemento materno | |
BR112017004703A2 (pt) | ?vacina e método para proteção de progênie de uma porca contra infeccção por um vírus de diarreia endêmica suína? |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |